Phase 2 clinical trial of AC105 (MG/peg) for treatment of acute spinal cord injury (SCI)
Ended Cooperative Agreement Awarded
- Award ID
- W81XWH1220136
- Recipient
-
Acorda Therapeutics, Inc. UEI R5D3FUPFFPK4
- Awarding agency
-
Department of Defense
- Obligated
- $5,350,016
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Hawthorne, NY 10532, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $2,675,008 | |
| Original award | $2,675,008 |
Quick answers
Who received award W81XWH1220136?
W81XWH1220136 was awarded to Acorda Therapeutics, Inc. by Department of Defense on September 30, 2012.
How much is award W81XWH1220136 worth?
$5,350,016 has been obligated on W81XWH1220136.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award